Deal watch: Amgen builds secondary hyperthyroidism pipeline.Published in:Nature Reviews Drug Discovery, 2012, v. 11, n. 6, p. 430, doi. 10.1038/nrd3768By:Tse, Man TsueyPublication type:Article
People.Published in:Nature Biotechnology, 2005, v. 23, n. 4, p. 506, doi. 10.1038/nbt0405-506Publication type:Article